SCHEMBL7917885

SCHEMBL7917885

CCOC(=O)C1=C(N)CN(Cc2ccccc2)C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
MAPT P10636 2/20 0.53
ADORA1 P30542 1/20 0.53
CASP3 P42574 2/20 0.52
PRMT1 Q99873 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.51
MAPK1 P28482 3/20 0.50
ALDH1A1 P00352 4/20 0.48
GAA P10253 2/20 0.48
TSHR P16473 2/20 0.48
KDM4E B2RXH2 1/20 0.48
HPGD P15428 1/20 0.48
CASP1 P29466 1/20 0.48
CASP7 P55210 1/20 0.48
HSD17B10 Q99714 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
CHRM2 P08172 1/20 0.48
CHRM4 P08173 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15420762 0.88 MEN1 (0.61) LMNAMEN1KMT2AMAPTADORA1
SCHEMBL4984893 0.88 MEN1 (0.61) LMNAMEN1KMT2AMAPTADORA1
SCHEMBL2490443 0.86 MEN1 (0.49) MEN1KMT2AMAPTCASP3SMN1; SMN2
SCHEMBL15415970 0.86 CASP3 (0.54) LMNAMEN1KMT2AMAPTADORA1
SCHEMBL20670367 0.84 CASP3 (0.52) LMNAMEN1KMT2AMAPTADORA1
SCHEMBL1752279 0.83 CHRM5 (0.62) CASP3CHRM2CHRM4CHRM5CHRM1
SCHEMBL2910520 0.81 LMNA (0.48) LMNAMEN1KMT2AMAPTADORA1
SCHEMBL29992308 0.81 CASP3 (0.49) LMNAMEN1KMT2AMAPTADORA1
SCHEMBL25322752 0.80 CASP3 (0.57) LMNAMEN1KMT2AMAPTADORA1
SCHEMBL20300563 0.77 MEN1 (0.57) LMNAMEN1KMT2AMAPTADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110257208-A1 COMPOUNDS USEFUL AS FAAH MODULATORS AND USES THEREOF RENOVIS, INC. 2011-10-20 US disclosed
US-20110257208-A1 COMPOUNDS USEFUL AS FAAH MODULATORS AND USES THEREOF RENOVIS, INC. 2011-10-20 US disclosed
WO-2010059610-A1 6, 7 -DIHYDRO- 5H- PYRROLO [3, 4-D] PYRIMIDIN-4-YL] -QUINOLIN-3 -YLAMINE COMPOUNDS USEFUL AS FAAH MODULATORS AND USES THEREOF RENOVIS, INC. (US) 2010-05-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257208-A1 COMPOUNDS USEFUL AS FAAH MODULATORS AND USES THEREOF FAAH, FAAH2, CNR2 LMNA 2513/4885MEN1 3296/4885KMT2A 3412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.